J. Safra Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
4,182
+85
+2% +$19.8K 0.05% 114
2026
Q1
$1M Buy
4,097
+300
+8% +$69.9K 0.05% 96
2025
Q4
$786K Buy
3,797
+3,076
+427% +$608K 0.04% 124
2025
Q3
$134K Hold
721
– – 0.01% 186
2025
Q2
$110K Hold
721
– – 0.01% 182
2025
Q1
$120K Hold
721
– – 0.01% 161
2024
Q4
$103K Hold
721
– – 0.01% 164
2024
Q3
$116K Hold
721
– – 0.01% 109
2024
Q2
$105K Sell
721
-326
-31% -$48.5K 0.01% 92
2024
Q1
$166K Buy
1,047
+286
+38% +$45.5K 0.02% 51
2023
Q4
$119K Buy
761
+40
+6% +$6.13K 0.02% 64
2023
Q3
$112K Hold
721
– – 0.02% 66
2023
Q2
$119K Hold
721
– – 0.02% 74
2023
Q1
$112K Buy
+721
New +$116K 0.02% 76
2022
Q3
– Hold
0
– – – 49
2022
Q2
– Hold
0
– – – 46
2022
Q1
– Hold
0
– – – 51
2016
Q4
– Sell
-602
Closed -$71K – 81
2016
Q3
$71K Sell
602
-168
-22% -$20.4K 0.12% 44
2016
Q2
$93K Sell
770
-2,881
-79% -$327K 0.15% 64
2016
Q1
$395K Buy
3,651
+2,251
+161% +$233K 0.32% 75
2015
Q4
$144K Buy
+1,400
New +$141K 0.11% 90

Other funds holding JNJ

J. Safra Asset Management's JNJ Position: Q2 2026 in Review

J. Safra Asset Management increased its Johnson & Johnson (JNJ) stake by 2.1% in Q2 2026, buying an estimated $19.8K and bringing the position to 4,182 shares worth $1.06M. The position accounts for 0.05% of the portfolio, ranked #114.

J. Safra Asset Management first reported a position in JNJ in Q4 2015 and has held it in 18 quarters since. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • J. Safra Asset Management held 4,182 shares of Johnson & Johnson worth $1.06M as of Q2 2026.
  • J. Safra Asset Management bought 85 Johnson & Johnson shares in Q2 2026, an estimated $19.8K.
  • Johnson & Johnson made up 0.05% of J. Safra Asset Management's portfolio in Q2 2026, its #114 holding.
  • J. Safra Asset Management first reported a position in Johnson & Johnson in Q4 2015 and has held it in 18 quarters since.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.